top of page

Search Results

Results found for "pain modeling"

  • Precise druggability of the PTH type 1 receptor

    prototypic class B GPCR target, and a combination of molecular dynamics simulations and elastic network model-based Here we found a key mechanical site that modulates the collective dynamics of the receptor and used this This study provides a computational pipeline to detect precise druggable sites and identify allosteric modulators

  • The regulation of PKA signaling in obesity and in the maintenance of metabolic health

    hormones, neurotransmitters and other signaling molecules that bind G-protein coupled receptors (GPCR) to modulate Mouse models have provided invaluable information on the roles for PKA subunits in brain and key metabolic

  • 📰 GPCR Weekly News, March 13 to 19, 2023

    A Rab10-ACAP1-Arf6 GTPases cascade modulates M4 muscarinic acetylcholine receptor trafficking and signaling Neurotensin Receptor Allosterism Revealed in Complex with a Biased Allosteric Modulator. α1-adrenoceptor A small molecule ligand for the novel pain target, GPR171, produces minimal reward in mice. Endogenous l- to d-amino acid residue isomerization modulates selectivity between distinct neuropeptide

  • Knowing When to Walk, Knowing When to Run: Lessons from the Bench

    A Final Aha Moment: Try the Crazy Idea When a collaborator offered a neuroma model (one where opioids Keyword Cloud: GPCR online course, early-career scientists, imposter syndrome, GPCR podcast, neuroma model

  • Assay Volume Control: Your GPCR Drug Discovery Power Lever

    Breakthroughs this week: C. elegans avoids EGCG via SRXA-7 GPCR; a bidirectional GPCR switch modulates We kick off with a question that cuts deep: What if your models could actually predict the future? Jens Carlsson  (Uppsala University) joins Yamina  to explore how computational modeling is evolving from

  • Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery

    (Bikker et al., 1998) Quantitative studies of how drugs modulate their targets have been instrumental Integrating mutagenesis data with computational models also presents challenges, requiring high-quality contributions, challenges such as data complexity, resource intensity, and integration with computational models G-protein coupled receptors: models, mutagenesis, and drug design.

  • Sweet taste receptor agonists attenuate macrophage IL‐1β expression and eosinophilic inflammation...

    macrophage IL‐1β overproduction, thereby suggesting autophagy regulation as a potential therapeutic modality therapeutic effects of trehalose and saccharin on macrophage IL‐1β production and eosinophilia in the mouse model

  • Is Your Agonist Really “Working”—Or Are You Just Seeing What Your System Allows?

    In this eye-opening module, Terry Kenakin explores a concept that could change how you interpret pharmacological think batteries and balance scales), Terry reveals why different tissues—and even different assays—can paint

  • 📰 GPCR Weekly News, February 6 to 12, 2023

    Isoform- and ligand-specific modulation of the adhesion GPCR ADGRL3/Latrophilin3 by a synthetic binder Binders, Drugs, and more An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models Quantitative analysis of sterol-modulated monomer-dimer equilibrium of the β1-adrenergic receptor by pulls off rare IPO, raising $161M 3-drug combo leads to 'unprecedented' response in pancreatic cancer models

  • Constitutive, Basal, and β-Alanine-Mediated Activation of the Human Mas-Related G Protein-Coupled ..

    coupled receptors (MRGPRs), a subfamily of GPCRs, are largely expressed by sensory neurons and known to modulate itch and pain.

  • Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors

    Mapping of Alphafold2 generated models of these proteins confirms that the same sites can be identified Results confirm the possibility of specifically targeting these sites across GPCRs for allosteric modulation

  • Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future

    preclinical data supports the applicability of CB2 activation in autoimmune and inflammatory diseases, pain

  • 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024

    , for their work on Isoquinoline small molecule ligands are agonists and probe-dependent allosteric modulators Pacific abalone Haliotis discus hannai GPCR Binders, Drugs, and more Photo-BQCA: Positive Allosteric Modulators of the M1 Receptor Isoquinoline small molecule ligands are agonists and probe-dependent allosteric modulators LPA3 agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory disease models

  • Developing the Cannabinoid Receptor 2 (CB2) pharmacopeia: past, present, and future

    preclinical data support the applicability of CB2 activation in autoimmune and inflammatory diseases, pain

  • CCL25/CCR9 interaction promotes the malignant behavior of salivary adenoid cystic carcinoma via...

    This study aimed to investigate the specific molecular mechanism by which CCR9/CCL25 modulates malignant The effect of CCL25 on the development of SACC in vivo was examined by a xenograft tumor model in nude

  • 📰 GPCR Weekly News, July 1 to 7, 2024

    for their investigation on Modulation of contextual fear acquisition and extinction by acute and chronic of cognate GPCRs and disrupt downstream intracellular signaling Therapeutic potential of allosteric modulators Neuroscience Neuron specific quantitation of Gαolf expression and signaling in murine brain tissue Modulation cortex Unveiling the therapeutic prospects of EGFR inhibition in rotenone-mediated parkinsonism in rats: Modulation immune balance and ameliorates type 2 diabetes mellitus Methods & Updates in GPCR Research Computational modelling

  • Irreversible Drugs, Real Control: Design for Durable Target Engagement

    Get Yearly Access On-Demand Now — Free 7 Day Trial ➤ DrGPCR Podcast: Jens Carlsson on Predictive Modeling Jens Carlsson shares how structure-based design, molecular dynamics, and smart collaboration turn models Ideal for scientists who want modeling to guide experiments, not just narrate them. Bridge the aisle —modelers × experimentalists for faster iteration. Listen to the episode ➤ Why Dr.

  • The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think

    from new pipelines targeting obesity to significant collaborations in cardiometabolic disease, and gain Terry's Corner - Unlock the Power of Target Residence Time in Your GPCR Drug Discovery Pipeline Gain Threat Avoided:  Prevent costly late-stage failures by incorporating kinetic modeling early in your pipeline Problem Solved:  Gain a deeper understanding of the pharmacological underpinnings of opioid overdose, GPCR University Course Attendee Ready to gain a competitive advantage?

  • 📰 GPCR Weekly News, March 4 to 10, 2024

    Gain invaluable skills in data analysis under Dr. Hoare's expert guidance. Receptors GPCRs in Neuroscience A M1 muscarinic acetylcholine receptor-specific positive allosteric modulator Alzheimer disease revealed by genomic analysis restricted to variants impacting gene function Interaction modes spectroscopy Up-regulation of GPR139 in the medial septum ameliorates cognitive impairment in two mouse models

  • Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR...

    Here, using colorectal cancer (CRC) as a model, we explored the gene expression of a panel of GPCRs in fluorescent ligands were effective at monitoring real-time A2BAR receptor labeling using live-imaging modalities

  • From Technician to Trailblazer: How Sokhom Pin Designed His Own PhD Program While Working in Industry

    That’s exactly what Sokhom Pin did. A Model for Future Scientists? His hybrid path is a model of possibility for professionals in the biotech industry who still dream of Takeaway If you’re navigating work, life, and scientific ambition, Sokhom Pin proves it’s possible to

  • A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.

    and has synergistic effects with anticancer agents.[1–3] These insights highlight the potential in modulating Translational Potential of Allosteric Modulators Targeting the Cannabinoid CB1 Receptor. for Neuropathic Pain Relief. A.; Bazin, H.; Tinel, N.; Durroux, T.; Prézeau, L.; Trinquet, E.; Pin, J.-P. Derivatives as New CB2 Cannabinoid Receptors Agonists: Synthesis, Pharmacological Properties and Molecular Modeling

  • Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling

    subfamilies such as Gs, Gi/o, Gq/11, and G12/13, which orchestrate downstream signaling events, including the modulation cost of reagents, optimizing sensor expression levels and adapting these systems to disease-relevant models Addressing these hurdles is essential for translating findings from cellular models to clinically relevant development of the BERKY and the ONE-GO biosensors, designed to facilitate their application in disease models

  • How Fast Does a Drug Work?

    In this session, you’ll gain: ✅ A practical framework for understanding when a drug’s rate of binding Don’t Let Outdated Models Slow Your Next Program The analytical tools that shaped traditional affinity You’ll gain clarity that accelerates your path from discovery to clinic: Know when your assays truly

  • 📰 GPCR Weekly News, May 22 to 28, 2023

    Modulating GPCR and 14-3-3 protein interactions: prospects for CNS drug discovery. Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief.

  • Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation

    Whit this scope, the authors challenged the current model, wich suggest that β-arrestin translocates Based on all the information collected, the authors proposed the following multistep model for receptor-β-arrestin Although this study has limitations, such as the absence of the flexible distal C-tail of βArr2 in the model used, its findings redefine the existing model of receptor-β-arrestin interactions. M., Medel-Lacruz, B., Baidya, M., Makarova, M., Mistry, R., Goulding, J., Drube, J., Hoffmann, C., Owen

  • Curve Shifts Don’t Lie, But Your Eyes Might

    In This Session, You’ll Gain: ✅ The ability to calculate how many replicates you really  need for 95% By comparing two means (paired or unpaired) you’ll learn whether the divergence is genuine or whether Sometimes you’re working with linear fits: Schild plots, dose ratios, regression models. insights  distilled from decades of pharmacology experience Whether you’re validating assays, refining models

  • Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery

    form biologically active homodimers or heterodimers which drive specific signaling pathways that can modulate al. recently provided key insights into GPCR oligomerization and biased signalling, using PAFR as a model Different models of dimer formation have been described for different receptors such as the ‘rolling dimer’ interface model in which multiple dimer conformations co-exist and interconvert (P.M.

  • Your GPCR Program Decisions Depend on Good Data Interpretation

    GPCR Premium Members this week gain curated, early access to: Industry insights : GPCRs and mRNA in drug Your Access To Terry's Corner ➤ Why the Myth of Multiple Affinity Sites Slows You Down Traditional models both pharma and startup environments Read Maria Majellaro's Full Recap ➤ Lab Leadership Without Ego: A Model At Alkermes, Sokhom Pin built an in vitro pharmacology group from scratch—not just a lab, but a culture

  • Unlock the Hidden Lives of Receptors – Are You Ready?

    What if the static models we've relied on for decades have been hiding the truth?

bottom of page